Other advances in breast cancer diagnosis and treatment are emerging as well. Many immunotherapy clinical trials are underway, paving the way for this new frontier in cancer treatment, and women with breast cancer may be able to participate in this research. For instance, immunotherapy-in which the body’s immune system is leveraged to fight cancer-has dramatically improved treatment options for other types of cancer, and results from early trials in breast cancer are promising (Solinas 2017). However, few true breakthroughs have emerged (Zurrida 2015).īut promising recent research may soon change the breast cancer treatment paradigm. Interventions that form the basis of most breast cancer treatment regimens today-surgery, chemotherapy, radiation, and hormone therapy-were fine-tuned from the 1980s into the early 21st century, leading to marginal outcome improvements. Thus, treatment options for women with breast cancer have not advanced dramatically in some time. About 250,000 women in the United States are diagnosed each year (ACS 2017a).Īlthough breast cancer research receives enormous funding from public and private sectors, much of the money goes toward studies on prevention and early detection.
MUFFIN KNIGHT EXTENSION SKIN
Breast cancer is the second-most-common cancer among American women, behind only skin cancer (NCCN 2016 U.S.
0 kommentar(er)
